BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. - Wikidata - awgldk - TriplyDB

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.

http://www.wikidata.org/entity/Q35066071

about

Novel therapeutic strategies for patients with triple-negative breast cancer The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development.BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions.Filamin A (FLNA) modulates chemosensitivity to docetaxel in triple-negative breast cancer through the MAPK/ERK pathway.Tackling breast cancer chemoresistance with nano-formulated siRNA.A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment.UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells

P2860

Q28067436-6000F34C-45A0-49FD-86EC-C904BC39335F Q33677289-56E39398-AD7F-41DF-A8C2-43E0E829240A Q37423763-03F54482-26C5-4D45-8776-3F07AF8F325A Q37705790-85B8A275-5C25-497C-8934-03D912305572 Q38821364-A9EFEB1C-AA6C-4BF8-A8D4-A118E7702670 Q38959517-7A37A9A2-31AA-4E4F-8776-3731AE2C0428 Q47275348-254C8F3E-1B80-4FBA-A63E-A83DEA67AB4C Q57787055-F772CEF8-7AF1-440A-9C2C-D4A08A1E87CD

P2860

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.

http://www.wikidata.org/entity/Q35066071

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

BRCA1-IRIS inactivation overco ...... riple negative breast cancers.

@ast

BRCA1-IRIS inactivation overco ...... riple negative breast cancers.

@en

type

label

BRCA1-IRIS inactivation overco ...... riple negative breast cancers.

@ast

BRCA1-IRIS inactivation overco ...... riple negative breast cancers.

@en

prefLabel

BRCA1-IRIS inactivation overco ...... riple negative breast cancers.

@ast

BRCA1-IRIS inactivation overco ...... riple negative breast cancers.

@en

P1433

Q35066071-5A127934-4AEF-4FC8-A9F8-69DF88A4A547

P1476

Q35066071-96FC67CA-7831-453B-BBF1-19CC21F3EB43

P2093

Q35066071-390324DF-589F-4F7F-9BA2-3558041424C4

Q35066071-4D661ECB-D8A8-4F80-B923-6DCBA3D2CA35

Q35066071-5FFC958E-EE42-4C96-9740-4EF4D73233F5

Q35066071-D2E1AC8E-7857-40EE-BA43-3BFD0416FFEF

P2860

Q35066071-01E2FF44-C778-481B-95CC-0E46082340E4

Q35066071-029C40EA-59F3-4B73-A16A-C3FDA0782DCD

Q35066071-02A22781-138D-416E-A73F-D3B56C09B118

Q35066071-0F910973-1EB8-42DE-BEEB-7F506E1CDD22

Q35066071-142CE120-EB2E-439E-9254-DC06CEF5ED9C

Q35066071-18B74C66-03CF-4DD0-A740-E0776EC7941B

Q35066071-1AA5E661-AC28-4A8B-8C4E-48634E4FE79A

Q35066071-1E9643F3-E675-4A7A-A895-835D54017A9C

Q35066071-22452012-DA47-4824-ABE3-55CB9480CCA9

Q35066071-22DAD49E-E461-46C8-8244-7598AD0EBE99

P2888

Q35066071-4B1E50C3-758A-4672-9184-E10761B3C9B8

P304

Q35066071-E4D65CFC-4B08-4521-87A4-ED6C06916F4E

P31

Q35066071-08CE8F32-DB78-4E8A-8AEB-691A03E92899

P356

Q35066071-876DB27B-1874-4570-BED9-1B882B98D580

P478

Q35066071-2FA670EA-6A30-4404-9F3C-D389FB92FA66

P577

Q35066071-246BDC55-2EB0-4843-90B6-9BF837060E7D

P5875

Q35066071-15073F4A-FD87-4D98-96D1-66F8023A5AAE

P6179

Q35066071-A9085AE4-7045-4B64-90C2-58709299ECE7

P698

Q35066071-3B992AAB-323F-495C-BC2D-5442CBBCB3DB

P932

Q35066071-2EAE4CA9-F2CC-4992-BC08-C2CC295678E0

P356

S13058-014-0512-9

P1433

Breast Cancer Research

P1476

BRCA1-IRIS inactivation overco ...... riple negative breast cancers.

@en

P2093

Barbara Craft

http://www.w3.org/2001/XMLSchema#string

Bibbin T Paul

http://www.w3.org/2001/XMLSchema#string

Wael M ElShamy

http://www.w3.org/2001/XMLSchema#string

Zannel Blanchard

http://www.w3.org/2001/XMLSchema#string

P2860

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

A new fork for clinical application: targeting forkhead transcription factors in cancer

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines

Targeting survivin in cancer therapy: fulfilled promises and open questions

Mitochondria and FOXO3: breath or die

Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer

A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.

A robust automated measure of average antibody staining in immunohistochemistry images

Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.

P2888

s13058-014-0512-9

P304

5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13058-014-0512-9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270910166

http://www.w3.org/2001/XMLSchema#string

P6179

1001259103

http://www.w3.org/2001/XMLSchema#string

P698

25583261

http://www.w3.org/2001/XMLSchema#string

P932

4322455

http://www.w3.org/2001/XMLSchema#string